Synthesis and cytotoxicity evaluation of novel indolylpyrimidines and indolylpyrazines as potential antitumor agents

Bioorganic and Medicinal Chemistry

Volumn 9, Issue 5, 2001, Pages 1149-1154

  Jiang, Biao ^a   Yang, Cai Guang ^a   Xiong, Wen Nan ^a   Wang, Jun ^a  

^a SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 (N,N DIMETHYL)AMINO 3,5 BIS(3' INDOLYL)PYRAZINE; 2 AMINO 3 (N TOSYL 3' INDOLYL) 5 BROMOPYRAZINE; 2,4 BIS(3' INDOLYL)PYRIMIDINE; 5 METHOXY 2,4 BIS(3' INDOLYL)PYRIMIDINE; 5 METHYL 2,4 BIS(3' INDOLYL)PYRIMIDINE; BIS(N TOSYLINDOLYL)PYRIMIDINE; INDOLYLPYRAZINE DERIVATIVE; INDOLYLPYRIMIDINE DERIVATRIVE; PYRAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BRAIN CANCER; BREAST CANCER; CANCER CELL CULTURE; COLON CANCER; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; KIDNEY CANCER; LEUKEMIA; LUNG NON SMALL CELL CANCER; MELANOMA; OVARY CANCER; PROSTATE CANCER; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; INDOLES; PYRAZINES; PYRIMIDINES; TUMOR CELLS, CULTURED;

EID: 0034997350     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(00)00337-0     Document Type: Article

References (25)

1. Nishizawa Y. Nature. 308:1984;693.
2. Nishizawa Y. Science. 233:1986;305.
3. Nishizawa Y. Nature. 334:1988;661.
4. Stewart A.F., Schultz G. Cell. 50:1987;1109.
5. Wu H.Y., Shyy S.H., Wang J.C., Liu L.F. Cell. 53:1988;433.
6. Merino A., Madden K.R., Lane W.S., Champoux J.J., Deinberg D. Nature. 365:1993;227.
7. Alvarez M., Salas M. Heterocycles. 32:1991;1391.
8. Wipf P. Chem. Rev. 95:1995;2115.
9. Faulkner D.J. Nat. Prod. Rep. 16:1999;155.
10. Wright A.E., Pomponi S.A., Cross S.S., McCarthy P. J. Org. Chem. 57:1992;4772.
11. Capon R.J., Rooney F., Murray L.M., Collins E., Sim A.T.R., Rostas J.A.P., Butler M.S., Carroll A.R. J. Nat. Prod. 61:1998;660.
12. Kohmoto S., Kashman Y., McConnell O.J., Rinehart K.L., Wright A. Jr., Koehn F. J. Org. Chem. 53:1988;3116.
13. Sakemi S., Sun H.H. J. Org. Chem. 56:1991;4304.
14. Kawasaki I., Yamashita M., Ohata M. Chem. Pharm. Bull. 44:1996;1831.
15. Gu X.-H., Wan X.-Z., Jiang B. Bioorg. Med. Chem. Lett. 9:1999;569.
16. Jiang B., Gu X.-H. Heterocycle. 53:2000;1559.
17. Jiang B., Gu X.-H. Bioorg. Med. Chem. 8:2000;363.
18. Franco L.H., Joffë E.B.K., Puricelli L., Tatian M., Seldes A.M., Palermo J.A. J. Nat. Prod. 61:1998;1130.
19. Jiang B., Yang C.-G. Heterocycles. 53:2000;1489.
20. Zheng Q., Yang Y., Martin A.R. Heterocycles. 37:1994;1761.
21. Camerino B., Palamidessi G. Gazz. Chim. Ital. 90:1960;1807.
22. Rubinstein L.V., Shoemaker R.H., Paull K.D., Simon R.M., Tosini S., Skehan P., Scudiero D.A., Monks A., Boyd M.R. J. Natl. Cancer Inst. 82:1990;1113.
23. Skehan P., Storeng R., Scudiero D.A., Monks A., McMahon J., Vistica D., Warren J.T., Bokesch H., Kenney S., Boyd M.R. J. Natl. Cancer Inst. 82:1990;1107.
24. Grever M.R., Schepatz S.A., Chabner B.A. Semin. Oncol. 19:1992;622.
25. Brachwitz V.H. J. Prakt. Chem. 311:1969;40.